Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Skyrizi
Marketing
AbbVie’s Skyrizi passes Lilly’s Omvoh to take lead in colitis
Spherix said Skyrizi has quickly blasted past Omvoh in ulcerative colitis, capturing more than double the market share two months after launch.
Nick Paul Taylor
Oct 7, 2024 10:53am
Dupixent takes pharma DTC top spot in September
Oct 7, 2024 10:00am
AbbVie maintains grip on TV drug ad spending list
Sep 5, 2024 10:22am
AbbVie's Skyrizi, Rinvoq retake top TV drug ad spenders' crown
Aug 12, 2024 10:08am
Takeda's Entyvio keeps its strong IBD position despite threats
Jul 31, 2024 4:43pm
With new FDA nod, AbbVie readies its Skyrizi in UC
Jul 25, 2024 12:10pm
